CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 44 filers reported holding CLEVELAND BIOLABS INC in Q3 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,000 | 0.0% | 164 | -95.3% | 0.00% | – |
| Q4 2014 | $1,000 | -66.7% | 3,476 | -45.7% | 0.00% | – |
| Q3 2014 | $3,000 | +50.0% | 6,399 | +45.5% | 0.00% | – |
| Q2 2014 | $2,000 | -33.3% | 4,399 | +12.8% | 0.00% | – |
| Q1 2014 | $3,000 | -50.0% | 3,899 | -20.4% | 0.00% | – |
| Q4 2013 | $6,000 | +20.0% | 4,899 | +46.9% | 0.00% | – |
| Q3 2013 | $5,000 | -86.1% | 3,336 | -85.5% | 0.00% | -100.0% |
| Q2 2013 | $36,000 | – | 23,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 697,300 | $1,102,000 | 0.26% |
| GOODNOW INVESTMENT GROUP, LLC | 601,889 | $951,000 | 0.17% |
| MACROVIEW INVESTMENT MANAGEMENT LLC | 38,000 | $60,000 | 0.06% |
| BHR Capital LLC | 300,000 | $474,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 746,200 | $1,172,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 67,200 | $106,000 | 0.02% |
| Van Cleef Asset Management,Inc | 20,000 | $32,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 69,981 | $111,000 | 0.01% |
| KINGS POINT CAPITAL MANAGEMENT | 10,000 | $16,000 | 0.01% |
| TAURUS ASSET MANAGEMENT, LLC | 15,000 | $24,000 | 0.01% |